GlassScriptPhysician profile
Morton J Singer
NPI 1497701304
$439.91
in general payments reported to CMS, 2019-2025
10 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $375 · 2020: $45.60 · 2022: $19.53.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Napo Pharmaceuticals INC | $118.12 | 2019 | |
| Janssen Products, LP | $99.95 | 2019 | |
| Abbott Laboratories | $45.76 | 2019-2020 | |
| Astellas Pharma US INC | $41.21 | 2019 | |
| Gilead Sciences, INC. | $37.23 | 2019-2020 | |
| Amgen INC. | $33.64 | 2019 | |
| Insulet Corporation | $20.44 | 2020 | |
| Daiichi Sankyo INC. | $19.53 | 2022 | |
| Lilly USA, LLC | $12.94 | 2019 | |
| Antares Pharma, INC. | $11.09 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Morton Singer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.